鎮痛期の英語

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。例文帳に追加

The sustained-release preparation contains at least one retarder in an effective amount enough to release the opioid analgesic at a rate effective for manifesting analgesic effect for about 24 hours or longer after orally administered to a relevant human patient and is characterized in giving an absorption half-life of 1 to about 8 h. - 特許庁

該薬剤の投与は、ＡＳＡの鎮痛効果についての危険域よりも低い治療有効１日量でのＡＳＡの初期の１回、数回または連続して毎日の投与を包含する。例文帳に追加

The dose of the medicine includes initial one time or several times, or continuous every day dose, with a treatment-effective one day dose amount of the ASA lower in dangerous zone concerning pain-killing effect of the ASA. - 特許庁

ジクロフェナク等の非ステロイド系抗炎症剤を単独で使用するよりも消炎作用を早期に発現させるとともに、その消炎作用を増強させる消炎鎮痛薬の提供。例文帳に追加

To provide an anti-inflammatory-and-analgesic pharmaceutical expressing its own anti-inflammatory activity earlier than the case with the single use of a nonsteroidal anti-inflammatory agent such as diclofenac and enhancing its own anti-inflammatory activity as well. - 特許庁

薬物として消炎鎮痛剤を外用剤として保持させたものを長期間使用してもかぶれ症状など起こさず、低皮膚刺激性である貼付剤組成物を提供する。例文帳に追加

To provide a plaster composition not causing a rash symptom even when an antiphlogistic sedative medicine is used for a long period in a state retained as an external preparation and having low irritation to the skin. - 特許庁

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。例文帳に追加

These sustained release opioid formulations include an effective amount of at least one retardant material to cause said opioid analgesic to be released at such a rate as to provide an analgesic effect after oral administration to a human patient for at least about 24 hours, and are characterized by providing an absorption half-life from 1 to about 8 hours. - 特許庁

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。例文帳に追加

Such the sustained-release opioid formulation contains an effective amount of at least one retardant material to cause the opioid analgesic to be released at a such a rate as to provide an analgesic effect after oral administration to a human patient for at least about 24 hours, and is characterized by an absorption half-life of from 1 to about 8 hours. - 特許庁

こうした持続放出性オピオイド製剤は、ヒト患者への経口投与後に少なくとも約２４時間にわたり鎮痛効果を発現するのに効果的な速度でオピオイド鎮痛薬を放出させる、有効量の少なくとも１種の遅延物質を含有し、１時間〜約８時間の吸収半減期を示す点に特徴がある。例文帳に追加

The sustained release opioid formulation contains an effective amount of at least one retardant material to cause the opioid analgesic to be released at such a rate as to provide an analgesic effect after oral administration to human patient for at least about 24 h, and is characterized by providing an absorption half-life of 1 to about 8 h. - 特許庁

ピーマンの胎座と隔壁が含有している血液の循環を活発にする薬理物質及び鎮痛作用と発毛促進の薬理物質を乾燥野菜にすることで、たやすく摂取できて長期の保存が出来る。例文帳に追加

As a result of this, it is possible to improve the fact that pimento is not conventionally known to contain the pharmacological substances in the placenta 3 and the septum 4 and the placenta and septum are disposed of or not effectively used. - 特許庁